Johnson and Johnson

US looking at joint production of Johnson & Johnson's COVID vaccine in India

As India reeled from a devastating second wave of coronavirus infections, the US rapidly deployed six planeloads of life-saving supplies in support of the country's fight against the pandemic.

published on : 11th May 2021

FDA inspection found problems at factory making J&J vaccine

Agency inspectors said a batch of the bulk drug substance for J&J's single-shot vaccine was contaminated with material used to make COVID-19 vaccines for another Emergent client, AstraZeneca.

published on : 22nd April 2021

Johnson & Johnson seeks permission for phase-III trial of its COVID vaccine in India, import licence

They said the company has sought an early meeting of the subject expert committee on COVID-19 of the Central Drugs Standard Control Organisation to take a decision on its application.

published on : 20th April 2021

Short pause of J&J vaccines over clots for a matter of days, says US FDA

Nearly 7 million J&J doses have been administered in the U.S., almost all without serious side effects.

published on : 13th April 2021

Johnson & Johnson delays vaccine rollout in Europe

Hundreds of thousands of doses of the vaccine were due to be shipped to Europe in the coming weeks.

published on : 13th April 2021

European Union reviews J&J clot link, widens AstraZeneca probe

The European Medicines Agency (EMA) said four "serious cases" of unusual blood clots had been reported with the Johnson & Johnson vaccine.

published on : 9th April 2021

US to distribute 4 million doses of Johnson & Johnson COVID vaccines by March 2

The single-shot vaccine -- the third type to be authorized -- is highly effective in preventing severe Covid-19, including against newer variants, US FDA said, before giving it the green light.

published on : 1st March 2021

US FDA gives emergency use authorisation to COVID-19 vaccine from Johnson & Johnson

The EUA allows the Janssen COVID-19 vaccine to be distributed in the US for use in individuals of 18 years of age or older.

published on : 28th February 2021

South Africa ahead of schedule in first phase of COVID-19 vaccination

The country of almost 59 million people, which has seen nearly 50,000 succumb to the virus, has been widely criticised for a slow procurement of vaccines and lack of strategy. 

published on : 27th February 2021

WHO urges EU, Big Pharma unity as J&J seeks US vaccine approval

Kluge reiterated the WHO's call for rich countries to help poorer parts of the world, urging them to donate spare doses after inoculating the most vulnerable parts of their populations.

published on : 5th February 2021

Jury awards more than $70M to woman in Johnson & Johnson lawsuit

A St Louis jury has awarded a California woman more than USD 70 million in her lawsuit alleging that years of using Johnson & Johnson's baby powder caused her cancer.

published on : 28th October 2016